VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 31 filers reported holding VIVOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,802 | -15.1% | 201,704 | 0.0% | 0.03% | -20.0% |
| Q4 2022 | $81,085 | -42.5% | 201,704 | -6.9% | 0.04% | -45.3% |
| Q3 2022 | $141,000 | -49.6% | 216,704 | 0.0% | 0.06% | -46.7% |
| Q2 2022 | $280,000 | -50.9% | 216,704 | +1.9% | 0.12% | -40.3% |
| Q1 2022 | $570,000 | +18.8% | 212,704 | -0.4% | 0.20% | +27.2% |
| Q4 2021 | $480,000 | -44.9% | 213,502 | -0.9% | 0.16% | -46.3% |
| Q3 2021 | $871,000 | -18.4% | 215,500 | 0.0% | 0.29% | -15.8% |
| Q2 2021 | $1,067,000 | – | 215,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 162,500 | $804,000 | 0.46% |
| BARD ASSOCIATES INC | 215,500 | $1,067,000 | 0.35% |
| Millrace Asset Group, Inc. | 93,993 | $465,000 | 0.24% |
| Archon Capital Management LLC | 215,000 | $1,064,000 | 0.12% |
| Penn Capital Management Company, LLC | 223,403 | $1,106,000 | 0.11% |
| GRIFFIN ASSET MANAGEMENT, INC. | 49,500 | $245,000 | 0.03% |
| K2 PRINCIPAL FUND, L.P. | 64,746 | $320,000 | 0.03% |
| Walleye Capital LLC | 150,000 | $743,000 | 0.02% |
| WMS Partners, LLC | 16,667 | $153,000 | 0.02% |
| Avalon Investment & Advisory | 189,739 | $939,000 | 0.02% |